152 related articles for article (PubMed ID: 26290357)
1. Disposition of Extended Release Levetiracetam in Normal Healthy Dogs After Single Oral Dosing.
Beasley MJ; Boothe DM
J Vet Intern Med; 2015; 29(5):1348-53. PubMed ID: 26290357
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of Single Oral Dose Extended-Release Levetiracetam in Healthy Cats.
Barnard L; Barnes Heller H; Boothe DM
J Vet Intern Med; 2018 Jan; 32(1):348-351. PubMed ID: 29114943
[TBL] [Abstract][Full Text] [Related]
3. Disposition of levetiracetam in healthy adult horses.
Cesar FB; Stewart AJ; Boothe DM; Ravis WR; Duran SH; Wooldridge AA
J Vet Pharmacol Ther; 2018 Feb; 41(1):92-97. PubMed ID: 28503770
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of levetiracetam after oral and intravenous administration of a single dose to clinically normal cats.
Carnes MB; Axlund TW; Boothe DM
Am J Vet Res; 2011 Sep; 72(9):1247-52. PubMed ID: 21879984
[TBL] [Abstract][Full Text] [Related]
5. Serum levetiracetam concentrations and adverse events after multiple dose extended release levetiracetam administration to healthy cats.
Barnes Heller H; Granick M; Van Hesteren M; Boothe DM
J Vet Intern Med; 2018 May; 32(3):1145-1148. PubMed ID: 29671898
[TBL] [Abstract][Full Text] [Related]
6. Assessment of levetiracetam bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy: Open-label, single-dose, randomized, four-way crossover study in healthy male volunteers.
Stockis A; Sargentini-Maier ML; Otoul C; Connor A; Wilding I; Wray H
Clin Ther; 2010 Sep; 32(10):1813-21. PubMed ID: 21194605
[TBL] [Abstract][Full Text] [Related]
7. Steady-state pharmacokinetics of intravenous levetiracetam in neurocritical care patients.
Spencer DD; Jacobi J; Juenke JM; Fleck JD; Kays MB
Pharmacotherapy; 2011 Oct; 31(10):934-41. PubMed ID: 21950640
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and Safety of Levetiracetam Extended-Release Tablets and Relative Bioavailability Compared with Immediate-Release Tablets in Healthy Chinese Subjects.
Wang M; Wang M; Zhang Q; Zong S; Lv C
Eur J Drug Metab Pharmacokinet; 2018 Aug; 43(4):405-413. PubMed ID: 29383569
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic evaluation of immediate- and extended-release formulations of levetiracetam in dogs.
Boozer LB; Platt SR; Haley AC; Linville AV; Kent M; Barron LE; Nie B; Arnold RD
Am J Vet Res; 2015 Aug; 76(8):719-23. PubMed ID: 26207970
[TBL] [Abstract][Full Text] [Related]
10. Levetiracetam rectal administration in healthy dogs.
Peters RK; Schubert T; Clemmons R; Vickroy T
J Vet Intern Med; 2014; 28(2):504-9. PubMed ID: 24417468
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of the anticonvulsant levetiracetam in neonatal foals.
MacDonald KD; Hart KA; Davis JL; Berghaus LJ; Giguère S
Equine Vet J; 2018 Jul; 50(4):532-536. PubMed ID: 29194744
[TBL] [Abstract][Full Text] [Related]
12. Levetiracetam pharmacokinetics in healthy dogs following oral administration of single and multiple doses.
Moore SA; Muñana KR; Papich MG; Nettifee-Osborne J
Am J Vet Res; 2010 Mar; 71(3):337-41. PubMed ID: 20187836
[TBL] [Abstract][Full Text] [Related]
13. Increased levetiracetam clearance associated with a breakthrough seizure in a pregnant patient receiving once/day extended-release levetiracetam.
Garrity LC; Turner M; Standridge SM
Pharmacotherapy; 2014 Jul; 34(7):e128-32. PubMed ID: 24807683
[TBL] [Abstract][Full Text] [Related]
14. Effect of chronic administration of phenobarbital, or bromide, on pharmacokinetics of levetiracetam in dogs with epilepsy.
Muñana KR; Nettifee-Osborne JA; Papich MG
J Vet Intern Med; 2015; 29(2):614-9. PubMed ID: 25711374
[TBL] [Abstract][Full Text] [Related]
15. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
[TBL] [Abstract][Full Text] [Related]
16. Modeling and simulation of intravenous levetiracetam pharmacokinetic profiles in children to evaluate dose adaptation rules.
Snoeck E; Jacqmin P; Sargentini-Maier ML; Stockis A
Epilepsy Res; 2007 Sep; 76(2-3):140-7. PubMed ID: 17851036
[TBL] [Abstract][Full Text] [Related]
17. Bioequivalence of two formulations of levetiracetam.
Franco Spínola AC; Almeida S; Filipe A; Neves RI; Tanguay M; Yritia M
Int J Clin Pharmacol Ther; 2008 Nov; 46(11):591-6. PubMed ID: 19000558
[TBL] [Abstract][Full Text] [Related]
18. Comparison of plasma and saliva concentrations of levetiracetam following administration orally as a tablet and as a solution in healthy adult volunteers.
Lins RL; Otoul C; De Smedt F; Coupez R; Stockis A
Int J Clin Pharmacol Ther; 2007 Jan; 45(1):47-54. PubMed ID: 17256450
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam: relative bioavailability and bioequivalence of a 10% oral solution (750 mg) and 750-mg tablets.
Coupez R; Straetemans R; Sehgal G; Stockis A; Lu ZS
J Clin Pharmacol; 2003 Dec; 43(12):1370-6. PubMed ID: 14615473
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of rectal levetiracetam as add-on treatment in dogs affected by cluster seizures or status epilepticus.
Cagnotti G; Odore R; Gardini G; Amedeo S; Bertone I; Guerriero G; Lentini L; Dappiano E; D'Angelo A
BMC Vet Res; 2018 Jun; 14(1):189. PubMed ID: 29914474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
